UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

☐ 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________.

 

Commission file number 000-25753

 

VISIUM TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Florida

 

87-0449667

(State of Incorporation)

 

(IRS Employer Identification No.)

 

4094 MAJESTIC LANE, SUITE 360

FAIRFAX, VA 22033

(Address of principal executive offices)

 

(703) 273-0383

Registrant’s telephone number, including area code:

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

N/A

 

N/A

 

N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer 

Accelerated filer 

Non-accelerated Filer 

Smaller Reporting Company 

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of the registrant’s Common Stock, $0.0001 par value per share, as of May 15, 2023, was 10,603,284.

 

When used in this quarterly report, the terms “Visium,” “the Company,” “we,” “our,” and “us” refer to Visium Technologies, Inc., a Florida corporation.

 

 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on our management's current beliefs, estimates and assumptions and on information currently available to management that we believe may affect our financial condition, results of operation, business strategy and financial need.  Such statements involve substantial risk and uncertainties. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, and objectives for future operations are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions.

 

These risks and uncertainties include, among other things, risks related to our expectations regarding global macro-economic conditions, including the effects of inflation, rising and fluctuating interest rates and market volatility on the global economy; our ability to estimate the size and growth of our total addressable market, and the development of the market for our products, which is new and evolving; our ability to effectively sustain and manage our growth and future expenses, achieve and maintain future profitability, attract new customers; the impact of the coronavirus pandemic (the “COVID-19 pandemic”) or its abatement, on our business, results of operations, financial condition, and future profitability and growth; the impact of the evolving COVID-19 pandemic on the businesses of our customers, partners and suppliers, and the economy; the effects of increased competition in our market and our ability to compete effectively; our ability to expand use cases within existing customers and vertical solutions; our ability to expand our operations and increase adoption of our platform internationally; our ability to expand our direct sales force, customer success team and strategic partnerships around the world; the sufficiency of our cash and capital resources to satisfy our liquidity needs; our ability to hire, retain and motivate qualified personnel, including executive level management; and our ability to successfully manage and integrate executive management transitions; uncertainties regarding the impact of general economic and market conditions, including as a result of regional and global conflicts or related government sanctions;.

 

Most of these factors are difficult to predict and are generally beyond our control.  Therefore, you should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. We undertake no obligation to update any forward-looking statements after the date of this Quarterly Report on Form 10-Q or to conform such statements to actual results or revised expectations, except as required by law.  Further information on potential factors that could affect our business is described under “Item 1A. Risk Factors” in our Annual Report on Form 10-K as filed with the United States Securities and Exchange Commission, or the SEC, on October 4, 2022. Readers are also urged to carefully review and consider the various disclosures we have made in this Quarterly Report on form 10-Q and in our Annual Report on Form 10-K.

 

 
2

 

 

vism_10qimg2.jpg

 

VISIUM TECHNOLOGIES, INC. AND SUBSIDIARIES

 

INDEX

 

PART I - FINANCIAL INFORMATION

 

4

 

Item 1. Financial Statements

 

4

 

Consolidated Balance Sheets – March 31, 2023 (unaudited) and June 30, 2022

 

4

 

Consolidated Statements of Operations - Three and Nine Months ended March 31, 2023 and 2022 (unaudited)

 

5

 

Consolidated Statements of Changes in Stockholders’ Deficit (unaudited) – Three and Nine Months ended March 31, 2023 and 2022

 

6

 

Consolidated Statements of Cash Flows - Nine Months Ended March 31, 2023 and 2022 (unaudited)

 

8

 

Notes to Consolidated Financial Statements (unaudited)

 

9

 

Item 2. Management’s Discussion and Analysis and Results of Operations

 

22

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

29

 

Item 4. Controls and Procedures

 

29

 

PART II - OTHER INFORMATION

 

30

 

Item 1. Legal Proceedings.

 

30

 

Item 1A. Risk Factors.

 

30

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

30

 

Item 3. Defaults Upon Senior Securities.

 

30

 

Item 4. Mine Safety Disclosures.

 

30

 

Item 5. Other Information.

 

30

 

Item 6. Exhibits

 

30

 

SIGNATURES

 

31

 

 

 
3

Table of Contents

 

PART I - FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

VISIUM TECHNOLOGIES, INC.
CONSOLIDATED BALANCE SHEETS

 

 

 

March 31,

2023

 

 

June 30,

2022(1)

 

 

 

(Unaudited)

 

 

 

ASSETS

 

Current assets:

 

 

 

 

 

 

Cash

 

$46,750

 

 

$136,990

 

Prepaid license fee

 

 

17,500

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

64,250

 

 

 

136,990

 

 

 

 

 

 

 

 

 

 

Total assets

 

$64,250

 

 

$136,990

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$661,164

 

 

$596,463

 

Accrued compensation

 

 

1,190,629

 

 

 

614,589

 

Due to officer

 

 

72,500

 

 

 

-

 

Accrued interest

 

 

434,076

 

 

 

404,712

 

Convertible notes payable, net of discount of $0 and $412,944

 

 

1,431,790

 

 

 

1,074,487

 

Derivative liabilities

 

 

182,316

 

 

 

35,297

 

Notes payable, net of discount of $11,738 and $0

 

 

343,262

 

 

 

205,000

 

Total current liabilities

 

 

4,315,737

 

 

 

2,930,548

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A Convertible Preferred Stock ($0.001 par value; 20,000,000 shares authorized, 13,992,340 shares issued and outstanding as of March 31, 2023 and June 30, 2022, respectively)

 

 

13,992

 

 

 

13,992

 

Series B Convertible Preferred Stock ($0.001 par value 30,000,000 shares authorized, 1,327,670 shares issued and outstanding as of March 31, 2023 and June 30, 2022, respectively)

 

 

1,328

 

 

 

1,328

 

Series AA Convertible Preferred Stock ($0.001 par value; 1 share authorized, 1 share issued and outstanding as of March 31, 2023 and June 30, 2022, respectively)

 

 

0

 

 

 

0

 

Common stock, $0.0001 par value, 1,000,000,000 shares authorized: 7,380,323 shares issued and 5,588,656 shares outstanding at March 31, 2023, and 2,903,804 shares issued and 2,896,385 shares outstanding at June 30, 2022, respectively (See Note 7)

 

 

559

 

 

 

288

 

Additional paid in capital

 

 

54,782,670

 

 

 

53,749,386

 

Accumulated deficit

 

 

(59,050,036 )

 

 

(56,558,552 )

Total stockholders’ deficit

 

 

(4,251,487 )

 

 

(2,793,558 )

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ deficit

 

$64,250

 

 

$136,990

 

  

 

(1)

Derived from audited financial statements.

 

See Notes to Unaudited Consolidated Financial Statements.

 

 
4

Table of Contents

  

VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net revenues

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

567,979

 

 

 

1,296,611

 

 

 

1,461,560

 

 

 

3,761,236

 

Development expense

 

 

73,755

 

 

 

78,289

 

 

 

175,707

 

 

 

274,614

 

Total Operating Expenses

 

 

641,734

 

 

 

1,374,900

 

 

 

1,637,267

 

 

 

4,035,850

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from Operations

 

 

(641,734 )

 

 

(1,374,900 )

 

 

(1,637,267 )

 

 

(4,035,850 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expenses):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on change in fair value of derivative liabilities

 

 

(50,384 )

 

 

(76,707 )

 

 

(84,246 )

 

 

(20,632 )

Derivative liability expense

 

 

(4,634 )

 

 

-

 

 

 

(62,773 )

 

 

-

 

Loss on extinguishment of debt

 

 

(15,068 )

 

 

-

 

 

 

(519,993 )

 

 

-

 

Interest expense

 

 

(20,265 )

 

 

(52,587 )

 

 

(187,205 )

 

 

(554,262 )

Total other income (expenses)

 

 

(90,354 )

 

 

(129,294 )

 

 

(854,217 )

 

 

(574,624 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(732,085 )

 

$(1,504,194 )

 

$(2,491,484 )

 

$(4,610,474 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per common share basic and diluted

 

$(0.16 )

 

$(0.55 )

 

$(0.72 )

 

$(1.86 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – basic and diluted

 

 

4,658,570

 

 

 

2,750,423

 

 

 

3,454,032

 

 

 

2,477,833

 

 

See Notes to Unaudited Consolidated Financial Statements.

 

 
5

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2023

(UNAUDITED)

 

For the three months ended March 31, 2023

 

 

 

Preferred

Stock -

Series A

$0.001

Par Value

 

 

Preferred

Stock -

Series B

$0.001

Par Value

 

 

Preferred

Stock -

Series AA

$0.001

Par Value

 

 

Common

Stock

$0.0001

Par Value

 

 

Additional Paid-in

 

 

Accumulated

 

 

Total Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance at December 31, 2022

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

3,986,103

 

 

$398

 

 

$54,304,833

 

 

$(58,317,951 )

 

$(3,997,400 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for consulting services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

58,333

 

 

 

6

 

 

 

18,078

 

 

 

 

 

 

 

18,084

 

Shares issued as compensation to employees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

230,000

 

 

 

23

 

 

 

71,277

 

 

 

 

 

 

 

71,300

 

Shares issued as compensation to directors and officers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

520,002

 

 

 

52

 

 

 

161,148

 

 

 

 

 

 

 

161,200

 

Shares issued for conversion of notes payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

727,550

 

 

 

73

 

 

 

213,345

 

 

 

 

 

 

 

213,418

 

Commitment shares issued pursuant to financing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,668

 

 

 

7

 

 

 

13,993

 

 

 

 

 

 

 

14,000

 

Net loss for the three months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(732,085 )

 

 

(732,085 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2023

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

5,588,656

 

 

$559

 

 

$54,782,670

 

 

$(59,050,036 )

 

$(4,251,487 )

 

For the nine months ended March 31, 2023

 

 

 

Preferred

Stock -

Series A

$0.001

Par Value

 

 

Preferred

Stock -

Series B

$0.001

Par Value

 

 

Preferred

Stock -

Series AA

$0.001

Par Value

 

 

Common

Stock

$0.0001

Par Value

 

 

Additional Paid-in

 

 

Accumulated

 

 

Total Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance at June 30, 2022

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

2,896,385

 

 

$288

 

 

$53,749,386

 

 

$(56,558,552 )

 

$(2,793,558 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for consulting services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

69,815

 

 

 

7

 

 

 

36,949

 

 

 

 

 

 

 

36,956

 

Shares issued as compensation to employees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

465,001

 

 

 

47

 

 

 

144,103

 

 

 

 

 

 

 

144,150

 

Shares issued as compensation to directors and officers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,045,932

 

 

 

105

 

 

 

360,908

 

 

 

 

 

 

 

361,013

 

Warrants issued  on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

186,972

 

 

 

 

 

 

 

186,972

 

Shares issued for conversion of notes payable and accrued interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

976,100

 

 

 

98

 

 

 

290,366

 

 

 

 

 

 

 

290,464

 

Commitment shares issued pursuant to financing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,668

 

 

 

7

 

 

 

13,993

 

 

 

 

 

 

 

14,000

 

Shares issued for exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

68,755

 

 

 

7

 

 

 

(7 )

 

 

 

 

 

 

0

 

Net loss for the nine months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,491,484 )

 

 

(2,491,484 )

Balance at March 31, 2023

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

5,588,656

 

 

$559

 

 

$54,782,670

 

 

$(59,050,036 )

 

$(4,251,487 )

 

See Notes to Unaudited Consolidated Financial Statements.

 

 
6

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2022

(UNAUDITED)

 

For the three months ended March 31, 2022

 

 

 

Preferred

Stock -

Series A

$0.001

Par Value

 

 

Preferred

Stock -

Series B

$0.001

Par Value

 

 

Preferred

Stock -

Series AA

$0.001

Par Value

 

 

Common

Stock

$0.0001

Par Value

 

 

Additional Paid-in

 

 

Accumulated

 

 

Total Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance at December 31, 2021

 

 

13,992,340

 

 

 

13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

2,681,534

 

 

$268

 

 

$52,469,274

 

 

$(54,471,321 )

 

$(1,984,045 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for consulting services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,000

 

 

 

6

 

 

 

381,294

 

 

 

 

 

 

 

381,300

 

Shares issued as compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,037

 

 

 

2

 

 

 

241,398

 

 

 

 

 

 

 

241,400

 

Amortization of deferred compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40,524

 

 

 

 

 

 

 

40,524

 

Commitment Shares pursuant to financing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,000

 

 

 

6

 

 

 

165,796

 

 

 

 

 

 

 

165,802

 

Net loss for the three months ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,504,194 )

 

 

(1,504,194 )

Balance at March 31, 2022

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

2,818,571

 

 

$282

 

 

$53,300,700

 

 

$(55,975,512 )

 

$(2,659,210 )

 

For the nine months ended March 31, 2022

 

 

 

Preferred

Stock -

Series A

$0.001

Par Value

 

 

Preferred

Stock -

Series B

$0.001

Par Value

 

 

Preferred

Stock -

Series AA

$0.001

Par Value

 

 

Common

Stock

$0.0001

Par Value

 

 

Additional Paid-in

 

 

Accumulated

 

 

Total Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance at June 30, 2021

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

2,182,423

 

 

$218

 

 

$48,512,312

 

 

$(51,365,037 )

 

$(2,837,187 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for consulting services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

120,123

 

 

 

12

 

 

 

1,110,619

 

 

 

 

 

 

 

1,110,631

 

Shares issued as compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

82,222

 

 

 

8

 

 

 

1,059,392

 

 

 

 

 

 

 

1,059,400

 

Shares issued for conversion of notes payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

146,701

 

 

 

15

 

 

 

831,033

 

 

 

 

 

 

 

831,048

 

Commitment shares issued pursuant to financings

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,000

 

 

 

6

 

 

 

165,796

 

 

 

 

 

 

 

165,802

 

Shares issued pursuant to sale of common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

222,222

 

 

 

22

 

 

 

1,499,978

 

 

 

 

 

 

 

1,500,000

 

Shares issued for exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,879

 

 

 

1

 

 

 

(1 )

 

 

 

 

 

 

-

 

Amortization of deferred compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

121,572

 

 

 

 

 

 

 

121,572

 

Net loss for the nine months ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,610,474 )

 

 

(4,610,474 )

Balance at March 31, 2022

 

 

13,992,340

 

 

$13,992

 

 

 

1,327,670

 

 

$1,328

 

 

 

1

 

 

$0

 

 

 

2,818,571

 

 

$282

 

 

$53,300,700

 

 

 

(55,975,512 )

 

$(2,659,210 )

 

See Notes to Unaudited Consolidated Financial Statements.

 

 
7

Table of Contents

  

VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Month Period Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(2,491,484 )

 

$(4,610,474 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

542,149

 

 

 

2,170,031

 

Amortization of debt discount

 

 

83,218

 

 

 

388,842

 

Derivative liability expense

 

 

62,773

 

 

 

-

 

(Gain) loss on change in fair value of derivative liability

 

 

84,246

 

 

 

20,362

 

Amortization of deferred compensation

 

 

-

 

 

 

121,572

 

Loss on extinguishment of debt

 

 

519,993

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

37,812

 

 

 

35,092

 

Prepaid license fee

 

 

(17,500 )

 

 

52,500

 

Accrued interest

 

 

150,008

 

 

 

60,640

 

Discount  on notes payable

 

 

-

 

 

 

13,958

 

Accrued compensation

 

 

576,045

 

 

 

5,265

 

Net cash used in operating activities

 

 

(452,740 )

 

 

(1,742,572 )

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from sale of common stock

 

 

-

 

 

 

1,500,000

 

Repayment of convertible notes payable

 

 

-

 

 

 

(115,000 )

Proceeds from convertible notes payable

 

 

140,000

 

 

 

810,000

 

Proceeds from promissory notes payable

 

 

150,000

 

 

 

-

 

Repayment of promissory notes payable

 

 

-

 

 

 

(225,000 )

Advances from officers

 

 

72,500

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash provided by financing activities

 

 

362,500

 

 

 

1,970,000

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash

 

 

(90,240 )

 

 

227,428

 

 

 

 

 

 

 

 

 

 

Cash, beginning of period

 

 

136,990

 

 

 

125,166

 

 

 

 

 

 

 

 

 

 

Cash, end of period

 

$46,750

 

 

$352,594

 

 

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$-

 

 

$22,011

 

Cash paid for income taxes

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Issuance of common stock for conversion of notes payable and accrued interest

 

$290,464

 

 

$831,048

 

Commitment shares issued for financing

 

 

14,000

 

 

 

165,802

 

Warrants issued on extinguishment of debt

 

$186,972

 

 

$-

 

 

See Notes to Unaudited Consolidated Financial Statements.

 

 
8

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 1: ORGANIZATION, GOING CONCERN AND BASIS OF PRESENTATION

 

Visium Technologies, Inc., or the Company, is a Florida corporation that was originally incorporated in Nevada in October 1987. It was formerly known as Jaguar Investments, Inc. between October 1987 and May 2003, Power2Ship, Inc. between May 2003 and November 2006, Fittipaldi Logistics, Inc. between November 2006 and December 2007, and as NuState Energy Holdings, Inc. between December 2007 and March 5, 2018 when it changed its name to Visium Technologies, Inc.

 

The Company is focused on digital risk management, cybersecurity, and technology services for network physical security, the Cloud, mobility solutions, critical infrastructure security, and the Internet of Things (“IOT”).

 

On March 11 2021 JAJ Advisory, LLC (“JAJ Advisory”) was formed in the State of Virginia as a wholly owned subsidiary of the Company. JAJ Advisory was established to account for non-cybersecurity and data analytics related business activities that the Company may pursue.

 

On June 20, 2022, the Company held a special meeting of stockholders, pursuant to which the stockholders of the Company voted approved certain corporate actions, and the Company filed an amendment to its Articles of Incorporation with the State Department of Corporations in the State of Florida to effect the following changes, effective September 22, 2022:

 

(i)

reverse our common stock by a ratio of one thousand three hundred fifty for one (1,350:1) (the “Reverse Split”). The board of directors was authorized to implement the Reverse Split.

 

 

(ii)

Reduce the number of shares of common stock that the Company is authorized to issue to one billion (1,000,000,000) from ten billion (10,000,000,000).

 

The principal effects of the Reverse Split include the following:

 

the number of outstanding shares of the Company’s common stock and treasury stock decreased based on the Reverse Split ratio of 1,350:1;

the number of shares of the Company’s common stock held by individual stockholders decreased based on the Reverse Split ratio of 1.350, and the number of stockholders who own “odd lots” of less than 100 shares of our common stock increased;

the number of shares of the Company’s common stock reserved for issuance under our stock incentive plans are reduced proportionally based on the Reverse Split ratio of 1,350:1 (along with any other appropriate adjustments or modifications); and

the exercise price of our outstanding stock options and warrants and the conversion price of our outstanding convertible securities, including preferred stock, and the number of shares reserved for issuance upon exercise or conversion thereof adjusted in accordance with their terms based on the Reverse Split ratio of 1,350:1.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis. For the nine months ended March 31, 2023 we had a net loss of $2,491,484, had net cash used in operating activities of $452,740 and had negative working capital of $4,251,487. These matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future. Management plans to provide for the Company’s capital requirements by continuing to issue additional equity and debt securities. The outcome of these matters cannot be predicted at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis of Presentation

 

The unaudited interim consolidated financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management are necessary to fairly state Visium Technologies, Inc.’s (the “Company” or “we”, “us” or “our”) financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to rules and regulations of the United States Securities and Exchange Commission (“SEC”), nevertheless, management of the Company believes that the disclosures herein are adequate to make the information presented not misleading.

 

These unaudited consolidated financial statements should be read in conjunction with the Company’s audited financial statements for the year ended June 30, 2022, contained in the Company’s Annual Report on Form 10-K filed with the SEC on October 4, 2022. The results of operations for the nine months ended March 31, 2023, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2023.

 

 
9

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Fiscal Year

 

The fiscal year ends on June 30. References to fiscal year 2023, for example, refer to the fiscal year ending June 30, 2023.

 

Principles of Consolidation

 

The accompanying consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles and include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements' the reporting amounts of revenues and expenses, and the valuation of shares issued for services during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets and derivative liability.

 

The COVID-19 pandemic and related developments have created and may continue to create significant uncertainty in global financial markets, which may decrease technology spending, depress demand for our products and harm our business and results of operations. As of the date of issuance of the financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. These estimates may change as new events occur and additional information is obtained, which could be recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid, temporary, cash equivalents or investments with an original maturity of three months or less when purchased, to be cash equivalents. The Company had no cash equivalents during the nine months ended March 31, 2023 and year ended June 30, 2022.

 

Concentration of Credit Risks

 

The Company is subject to a concentration of credit risk from cash.

 

The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000. The Company did not have cash on deposit in excess of such limit on March 31, 2023 and June 30, 2022.

 

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of March 31, 2023 and June 30, 2022 which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any.

 

 
10

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued

 

Fair Value of Financial Instruments

 

The Company accounts for assets and liabilities measured at fair value on a recurring basis, in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.

 

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

 

Level 1:

Observable inputs such as quoted market prices in active markets for identical assets or liabilities.

 

 

Level 2:

Observable market-based inputs or unobservable inputs that are corroborated by market data.

 

 

Level 3:

Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

At March 31, 2023, the estimated fair values of the liabilities measured on a recurring basis are as follows:

 

 

 

Fair Value Measurements at

 

 

 

June 30, 2022:

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Derivative liability – Convertible notes

 

 

 

 

 

 

 

 

182,316

 

Derivative liability – Warrants

 

$-

 

 

$-

 

 

$-

 

Total derivative liability

 

$-

 

 

$-

 

 

$182,316

 

 

The following is the Level 3 activity for the Company’s derivatives:

 

Derivative liability at June 30, 2020

 

$35,297

 

Increase due to issuance of convertible note

 

 

62,773

 

Loss on change in fair value of derivative liability

 

 

84,246

 

Derivative liability at June 30, 2021

 

$182,316

 

 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash, accounts payable and accrued expenses, accrued compensation, notes payable and convertible promissory notes payable, approximate their fair value due to the short maturity of these items or the use of market interest rates.

 

Convertible Instruments

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with ASC 470-20, Debt with Conversion and Other Options. Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40, Contracts in Entity’s own Equity, generally provides that, among other things, if an event is not within the entity’s control, such contract could require net cash settlement and shall be classified as an asset or a liability.

 

The Company determines whether the instruments issued in the transactions are considered indexed to the Company’s own stock. During fiscal years 2014 through 2022 the Company’s issued convertible securities with variable conversion provisions that resulted in derivative liabilities. See discussion above under derivative liabilities that resulted in a change in derivative liability accounting.

 

Revenue Recognition

 

All revenues are recorded in accordance with ASC 606, which is recognized when: (i) a contract with a client has been identified, (ii) the performance obligation(s) in the contract have been identified, (iii) the transaction price has been determined, (iv) the transaction price has been allocated to each performance obligation in the contract, and (v) the Company has satisfied the applicable performance obligation over time.

 

 
11

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued

 

Income Taxes

 

The Company accounts for income taxes pursuant to the provisions of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

 

The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions”. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of March 31, 2023, the Company had not filed tax returns for the tax years ending June 30, 2008 through 2022 and such returns, when filed, potentially will be subject to audit by the taxing authorities for a minimum of three years beyond the filing date under the three-year statute of limitations. The Company has not accrued any potential tax penalties associated with not filing these tax returns. Due to recurring losses, management believes such potential tax penalties, if any, would not be material in amount.

 

Share-Based Payments

 

The Company accounts for stock-based compensation in accordance with ASU 2022-07, Compensation – Stock Compensation (Topic 718). This update is intended to reduce cost and complexity and to improve financial reporting for share-based payments issued to non-employees (for example, service providers, external legal counsel, suppliers, etc.). The ASU expands the scope of Topic 718, Compensation—Stock Compensation, which currently only includes share-based payments issued to employees, to also include share-based payments issued to non-employees for goods and services. Consequently, the accounting for share-based payments to non-employees and employees is substantially aligned.

 

Under ASC Topic 718, “Compensation – Stock Compensation”. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.

 

The Company has elected to use the Cox, Ross & Rubinstein Binomial Tree valuation model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

Segment Reporting

 

The Company operates in one business segment which technologies are focused on cybersecurity and data analytics.

 

 
12

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued

 

Recent Accounting Pronouncements

 

The Company has reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company’s financial management.

 

In August 2022, the FASB issued ASU 2022-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) – Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exceptions. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.

 

In May 2022, the FASB issued ASU 2022-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this new guidance will have on its financial statements.

 

 
13

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued

 

Basic and Diluted Earnings Per Share

 

Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of shares of Common Stock outstanding during each period. Diluted earnings per share are computed using the weighted average number of shares of Common Stock and the dilutive Common Stock share equivalents outstanding during the period. Dilutive Common Stock share equivalents consist of shares issuable upon the exercise of in-the-money stock options and warrants (calculated using the modified-treasury stock method) and conversion of other securities such as convertible debt or convertible preferred stock. Potential common shares that would be as follows:

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Weighted average common shares outstanding

 

 

3,454,032

 

 

 

2,424,513

 

Effect of dilutive securities-when applicable:

 

 

 

 

 

 

 

 

Convertible promissory notes

 

 

4,846,219

 

 

 

71,045

 

Preferred stock

 

 

11,348

 

 

 

11,348

 

Common stock options

 

 

2,222

 

 

 

5,926

 

Warrants

 

 

66,781

 

 

 

5,049

 

Fully diluted earnings per share—adjusted weighted-average shares and assumed conversions

 

 

8,380,602

 

 

 

2,517,881

 

 

NOTE 3: PREPAID LICENSE FEE

 

In April 2021, the Company entered into a two-year software license agreement to enable product development. The license fee is prepaid at a rate of $70,000 annually, beginning July 1 of each year. The prepaid license fee is amortized on a straight-line basis over the term of the license agreement, and is included in Development expense in our Statement of Operations. As of March 31, 2023, the prepaid license fee was $17,500.

 

NOTE 4: DERIVATIVE LIABILITIES

 

Derivative liability – warrants

 

The Company issued warrants in connection with convertible notes payable issued in January, February, and July 2022. These warrants have price protection provisions that allow for the reduction in the exercise price of the warrants in the event the Company subsequently issues stock or securities convertible into stock at a price lower than the stated conversion for each warrant, ranging from $0.0055 to $0.02 per share exercise price of the warrants. Simultaneously with any reduction to the exercise price, the number of shares of common stock that may be purchased upon exercise of each of these warrants shall be increased or decreased proportionately, so that after such adjustment the aggregate exercise price payable for the adjusted number of warrants shall be the same as the aggregate exercise price in effect immediately prior to such adjustment. Because it is indeterminate whether a sufficient number of authorized and unissued shares will exist at the assessment date, the Company calculates a derivative liability associated with the warrants in accordance with FASB ASC Topic 815-40-25. Please note that these are derivatives but not recorded as the overall expense is immaterial.

 

Accounting for Derivative Warrant Liability

 

The Company’s derivative warrant instruments have been measured at fair value at March 31, 2023 using the Cox, Ross & Rubinstein Binomial Tree valuation model. The Company recognizes the derivative liability related to those warrants that contain price protection features in its consolidated balance sheet as liabilities. The liability is revalued at each reporting period and changes in fair value are recognized currently in the consolidated statements of operations. The initial recognition and subsequent changes in fair value of the derivative warrant liability have no effect on the Company’s cash flows.

 

Derivative liability – convertible notes

 

The Company has certain convertible notes with variable price conversion terms. Upon the issuance of these convertible notes and as a consequence of their conversion features, the convertible notes give rise to derivative liabilities. The Company’s derivative liabilities related to its convertible notes payable have been measured at fair value at March 31, 2023 and June 30, 2022 using the Cox, Ross & Rubinstein Binomial Tree valuation model.

 

The revaluation of the warrants and convertible debt at each reporting period, as well as the charges associated with issuing additional convertible notes, and warrants with price protection features, resulted in the recognition of a loss of $84,246 and $20,362 for the nine months ended March 31, 2023 and 2022, respectively in the Company’s consolidated statements of operations, under the caption “Loss on change of fair value of derivative liabilities”. These balances are reported on the consolidated balance sheet under the caption “Derivative liabilities”.

 

The Company has determined its derivative liabilities to be a Level 3 fair value measurements. The significant assumptions used in the Cox, Ross & Rubinstein Binomial Tree valuation of the derivatives are as follows:

 

 

 

Nine months ended March 31,

 

 

 

2023

 

 

2022

 

Effective exercise price

 

$

0.107 – $0.139

 

 

$

1.89 – $27.00

 

Effective market price

 

$0.1945

 

 

$

3.645

 

Expected volatility

 

 

303.27%

 

175.2% to 291.1

%

Risk-free interest

 

 

4.79%

 

0.35%-2.28

Expected terms

 

60 - 193 days

 

 

60 - 915 days

 

Expected dividend rate

 

 

0%

 

 

0

%

 

Changes in the derivative liabilities during the Nine Months Ended March 31, 2023 is follows:

 

Derivative liabilities at June 30, 2022

 

$35,297

 

Initial derivative liability expense

 

 

62,773

 

Loss on change in fair value of derivative liabilities

 

 

84,246

 

Derivative liabilities at March 31, 2023

 

$182,316

 

 

 
14

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 5: ACCRUED INTEREST PAYABLE

 

Changes in accrued interest payable during the Nine Months Ended March 31, 2023 is as follows:

 

Accrued interest payable at June 30, 2022

 

$404,712

 

Interest expense accrued for the nine months ended March 31, 2023

 

 

90,564

 

Conversion of accrued interest into common stock

 

 

(61,200 )

Accrued interest payable at March 31, 2023

 

$434,076

 

 

NOTE 6: CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE

 

Convertible Notes Payable

 

At March 31, 2023 and June 30, 2022 convertible debentures consisted of the following:

 

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

Convertible notes payable

 

$1,431,790

 

 

$1,487,431

 

Discount on convertible notes

 

 

-

 

 

 

(412,944 )

Convertible notes, net

 

 

1,431,790

 

 

 

1,074,487

 

 

The Company had convertible promissory notes aggregating $1,431,790 and $1,074,487 at March 31, 2023 and June 30, 2022, respectively. The related accrued interest amounted to approximately $230,000 and $197,800 at March 31, 2023 and June 30, 2022, respectively. The convertible notes payable bear interest at rates ranging from 0% to 18% per annum. The convertible notes are generally convertible, at the holders’ option, at rates ranging from $0.21 to $22,500 per share, as a result of the two reverse stock splits. At March 31, 2023, approximately $324,000 of convertible promissory notes had matured, are in default and remain unpaid. There are no punitive default provisions included in the terms of these convertible promissory notes.

 

The changes in the convertible notes payable balance is summarized below:

 

Convertible payable at June 30, 2022

 

$1,487,431

 

Convertible notes issued during the nine months ended March 31, 2023

 

 

149,250

 

Conversion of convertible notes payable into common stock

 

 

(204,891 )

Convertible payable at March 31, 2023

 

$1,431,790

 

 

In September 2022, we issued 138,667 warrants with a five year life, and a fixed exercise price of $1.35 per share, as part of a modification to three outstanding convertible notes payable. The Company evaluated these amendments under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the issuance of these warrants in exchange for deferring the interim interest payments that were due resulted in significant and consequential changes to the economic substance of the debt and thus resulted in accounting for these modifications as an extinguishment of the debt.  Under ASC 470-50, the issuance of these warrants resulted in a loss on the extinguishment of debt, as follows:

 

Value of warrants issued

 

$186,972

 

Write-off of unamortized debt discount

 

 

317,953

 

Loss on extinguishment of debt

 

$504,925

 

 

During the nine months ended March 31, 2023 we recorded a loss on the conversion of convertible note totaling $15,068, which is recorded in the Consolidated Statement of Operations as loss on extinguishment of debt.

 

 
15

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 6: CONVERTIBLE NOTES PAYABLE AND NOTES PAYABLE, continued

 

For the nine months ended March 31, 2023, the following summarizes the conversion of debt for common shares:

 

 

 

 

 

Amount of

 

 

 Amount of

 

 

 

 

Adjustment

 

 

 

 

Conversion

 

 

 

Shares

 

 

Converted

 

 

 Converted

 

 

Conversion

 

 

To

 

 

 

 

Price

 

Name

 

Issued

 

 

Principal

 

 

Interest

 

 

Expense

 

 

Fair Value

 

 

Total

 

 

Per Share

 

Talos Victory Fund

 

 

325,000

 

 

$86,450

 

 

$10,800

 

 

$3,500

 

 

$(12,920 )

 

$87,830

 

 

$0.27

 

FirstFire

 

 

260,000

 

 

 

31,250

 

 

 

21,600

 

 

 

1,750

 

 

 

18,226

 

 

 

72,826

 

 

 

0.28

 

Mast Hill

 

 

391,100

 

 

 

87,191

 

 

 

28,800

 

 

 

5,250

 

 

 

9,762

 

 

 

129,808

 

 

 

0.33

 

Total

 

 

976,100

 

 

$204,891

 

 

$61,200

 

 

$10,500

 

 

$13,873

 

 

$290,464

 

 

$0.30

 

 

Notes Payable

 

The Company had promissory notes aggregating $343,262 net of a discount of $11,738, and $205,000 at March 31, 2023 and June 30, 2022, respectively. The related accrued interest amounted to approximately $205,000 and $207,000 at March 31, 2023 and June 30, 2022, respectively. The notes payable bear interest at rates ranging from 0% to 16% per annum and are payable monthly. Promissory notes totaling $205,000 as of March 31, 2023 have matured, are in default, and remain unpaid.

 

In February 2023 the Company issued promissory notes totaling $150,000 to two accredited investors. The notes have a term of one year, and bear interest at 12%.

 

At March 31, 2023 and June 30, 2022 promissory notes consisted of the following:

 

 

 

March 31,

 

 

June 30,

 

 

 

2023

 

 

2022

 

Promissory notes payable

 

$355,000

 

 

$205,000

 

Discount on promissory notes payable

 

 

(11,738 )

 

 

-

 

Promissory notes payable, net

 

$343,262

 

 

$205,000

 

 

NOTE 7: STOCKHOLDERS’ DEFICIT

 

Common Stock

 

At March 31, 2023, the Company had 1,000,000,000 authorized common shares.

 

The Company effected a reverse split of our Common stock by a ratio of one thousand three hundred fifty for one (1,350:1). The board of directors of the Company was authorized to implement the reverse stock split effective September 22, 2022. The reverse stock split adjusted the then outstanding Common shares of the company from 3,916,144,800 common shares to a total of 2,896,396 common shares. This action also reduced the number of authorized common shares of the Company from 10,000,000,000 to 1,000,000,000.  Unless otherwise noted, all references to common stock share and per share amounts have been adjusted to reflect the reverse split.

 

Issuances of Common Stock During the Nine Months Ended March 31, 2023

 

Convertible Notes Payable

During the nine months ended March 31, 2023 the Company issued 976,100 shares of its common stock related to the conversion of $290,464 of principal and accrued interest and conversion expense for three of its convertible notes payable, at an average contract conversion price of $0.30 per share.  These convertible notes have terms that include fixed conversion prices, and therefore the notes were converted consistent with the contractual conversion prices of each note.

 

Stock Based Compensation

During the nine months ended March 31, 2023 the Company issued 1,045,932 shares of its $0.0001 par value common stock as compensation to its directors and officers. The shares were valued at $361,013, or $0.35 per share, based on the share price at the time of the transactions.

 

During the nine months ended March 31, 2023 69,815 shares of its $0.0001 par value common stock vested to two consultants, as compensation under two separate consulting agreements. The shares were valued at $36,956, or $0.53 per share, based on the share price at the time of the transactions.

 

During the nine months ended March 31, 2023 the Company issued 465,001 shares of its $0.0001 par value common stock as compensation to its employees. The shares were valued at $144,150, or $0.31 per share, based on the share price at the time of the transaction.

 

Warrant Exercises

During the nine months ended March 31, 2023 the Company issued 68,755 shares of its $0.0001 par value common stock pursuant to two cashless exercises.

 

Commitment Shares

During the nine months ended March 31, 2023 the Company issued 66,668 shares of its $0.0001 par value common stock to two investors as commitment shares pursuant to the issuance of promissory notes.  The shares were valued at $14,000, or $0.21 per share, the market price on the date of the issuance and was accounted for as discount on the related notes payable, which is being amortized over the term of the note.

 

 
16

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 7: STOCKHOLDERS’ DEFICIT, continued

 

Preferred Stock

 

Series A and B issued and outstanding shares of the Company’s convertible preferred stock have a par value of $0.001. All classes rank(ed) prior to any class or series of the Company’s common stock as to the distribution of assets upon liquidation, dissolution or winding up of the Company or as to the payment of dividends. All preferred stock shall have no voting rights except if the subject of such vote would reduce the amount payable to the holders of preferred stock upon liquidation or dissolution of the company and cancel and modify the conversion rights of the holders of preferred stock as defined in the certificate of designations of the respective series of preferred stock.

 

Series A Convertible Preferred Stock

 

The Series A Preferred Stock has a stated value of $750.00 per share. Each one share of Series A Preferred Stock is convertible into one (1) share of Common Stock. In the event the Common Stock price per share is lower than $0.10 (ten cents) per share then the Conversion shall be set at $0.035 per share. The Common Stock shares are governed by Lock-Up/Leak-Out Agreements.

 

Series B Convertible Preferred Stock

 

Thirty million (30,000,000) shares of preferred stock were designated as a new Series B Preferred stock in April 2016. This new Series B Preferred Stock has a $0.001 par value, and each 300 shares is convertible into one share of the Company’s common stock, with a stated value of $375 per share.

 

Series AA Convertible Preferred Stock

 

In March 2018, the Company authorized and issued one share of Series AA convertible preferred stock which provides for the holder to vote on all matters as a class with the holders of Common Stock and each share of Series AA Convertible Preferred Stock shall be entitled to 51% of the common votes on any matters requiring a shareholder vote of the Company. Each one share of Series AA Convertible Preferred Stock is convertible into one (1) share of Common Stock. Mark Lucky, our CFO, is the holder of the one share of Series AA Convertible Preferred Stock.

 

Common Stock Warrants

In January and February 2021, we issued 2,268 warrants with a two year life, and fixed exercise prices ranging from $7.425 to $27.00 per share.

 

In July and October 2021 we issued 2,781 warrants with a three year life, and fixed exercise prices of $10.3957, $12.285, and $20.385.

 

In September 2022 we issued 138,667 warrants with a fair value of $186,972 and a five year life, and a fixed exercise price of $1.35 per share, as part of a modification to three outstanding convertible notes payable. The Company evaluated these amendments under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the issuance of these warrants in exchange for deferring the interim interest payments that were due resulted in significant and consequential changes to the economic substance of the debt and thus resulted in accounting for these modifications as an extinguishment of the debt.  The Company recorded a loss of extinguishment of debt of $519,993. The Company used a binomial option pricing model to estimate the fair value of the warrants issued, using the following assumptions on the date that the warrants were issued:

 

Expected volatility

 

 

285.9%

Expected term

 

5 years

 

Risk-free interest rate

 

 

3.54%

Forfeiture Rate

 

 

0%

Expected dividend yield

 

 

0%

 

 
17

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 7: STOCKHOLDERS’ DEFICIT, continued

 

A summary of the status of the Company’s outstanding common stock warrants as of March 31, 2023 and changes during the fiscal year ending on that date is as follows:

 

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

Common Stock Warrants

 

 

 

 

 

 

Balance at beginning of year

 

 

5,049

 

 

$14.85

 

Granted

 

 

138,667

 

 

$1.35

 

Exercised

 

 

(68,755)

 

 

1.35

 

Forfeited

 

 

8,180)

 

 

1.35

 

Balance at end of period

 

 

66,781

 

 

$1.89

 

 

 

 

 

 

 

 

 

 

Warrants exercisable at end of period

 

 

66,781

 

 

$1.89

 

 

The following table summarizes information about common stock warrants outstanding at March 31, 2023:

 

 

 

 

Warrants Outstanding

 

 

Warrants Exercisable

 

Range of Exercise Price

 

 

Number

Outstanding at

March 31,

2023

 

 

Weighted

Average

Remaining

Contractual Life

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable at

March 31,

2023

 

 

Weighted

Average

Exercise

Price

 

$

1.35

 

 

 

64,000

 

 

4.42 Years

 

$1.35

 

 

 

64,000

 

 

$1.35

 

$

10.395

 

 

 

631

 

 

0.28 Years

 

$10.395

 

 

 

631

 

 

$10.395

 

$

12.285

 

 

 

1,339

 

 

1.51 Years

 

$12.285

 

 

 

1,339

 

 

$12.285

 

$

20.385

 

 

 

811

 

 

1.51 Years

 

$20.385

 

 

 

811

 

 

$20.385

 

 

 

 

 

 

66,781

 

 

4.14 Years

 

$1.89

 

 

 

66,781

 

 

$1.89

 

 

As of March 31, 2023, the Company had $0 of unrecognized nonvested expenses related to these warrants.

 

 
18

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 8 - STOCK-BASED COMPENSATION

 

The Company adopted a Stock Incentive Plan on April 18, 2021. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. While the 2021 Stock Incentive Plan terminates 10 years after the adoption date, issued options have their own schedule of termination. Options to acquire shares of common stock may be granted at no less than fair market value on the date of grant. Upon exercise, shares of new common stock are issued by the Company.

 

Under the 2021 Stock Incentive Plan, the Company has issued options to purchase 11,852 shares at an average price of $20.25 with a fair value of $0.00. For the nine months ended March 31, 2023 and 2022, the Company did not issue any options to purchase shares, respectively. Upon exercise, shares of new common stock are issued by the Company.

 

For the nine months ended March 31, 2023 and 2022, the Company did not recognize any, respectively, of non-cash compensation expense (which would be included in General and Administrative expense in the accompanying Consolidated Statement of Operations) determined by application of a binomial option pricing model with the following inputs: exercise price, dividend yields, risk-free interest rate, and expected annual volatility. As of March 31, 2023, the Company had no unrecognized pre-tax non-cash compensation expense. The Company used straight-line amortization of compensation expense over the one-year requisite service or vesting period of the grant. The Company recognizes forfeitures as they occur. There are options to purchase approximately 2,222 shares that have vested as of March 31, 2023.

 

The Company uses a binomial option pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the binomial option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

 

 

Nine months ended

March 31,

 

 

Year ended

June 30,

 

 

 

2023

 

 

2022

 

Expected volatility

 

370% - 497

%

 

370%-497

%

Expected term

 

4 Years

 

 

4 Years

 

Risk-free interest rate

 

0.76%-0.84

%

 

0.76%-0.84

%

Forfeiture Rate

 

 

0.00%

 

 

0.00%

Expected dividend yield

 

 

0.00%

 

 

0.00%

 

The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

 

A summary of the status of the Company’s outstanding stock options as of March 31, 2023 and June 30, 2022 and changes during the periods ending on that date is as follows:

 

 

 

 

 

 

Weighted Average

 

 

Grant Date

 

 

Aggregate

 

 

Weighted

Average

 

 

 

 

 

 

Exercise

 

 

Fair

 

 

Intrinsic

 

 

Remaining

 

 

 

Shares

 

 

Price

 

 

Value

 

 

Value

 

 

Term (Yrs)

 

Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At June 30, 2022

 

 

2,222

 

 

$27.00

 

 

$-

 

 

$0

 

 

 

3.08

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeiture and cancelled

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

At March 31, 2023

 

 

2,222

 

 

$27.00

 

 

$-

 

 

$0

 

 

 

3.08

 

 

 
19

Table of Contents

 

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 8 - STOCK-BASED COMPENSATION, continued

 

The following table summarizes information about employee stock options outstanding at March 31, 2023:

 

 

 

 

Outstanding Options

 

 

Vested Options

 

 

 

 

Number

 

 

 

 

 

 

Number

 

 

 

 

 

 

 

 

Outstanding

 

 

Weighted

 

 

Weighted

 

 

Exercisable

 

 

Weighted

 

 

Weighted

 

 

 

 

at

 

 

Averaged

 

 

Averaged

 

 

at

 

 

Averaged

 

 

Averaged

 

 

 

 

March 31,

 

 

Remaining

 

 

Exercise

 

 

March 31,

 

 

Exercise

 

 

Remaining

 

Range of Exercise Price

 

 

2022

 

 

Life

 

 

Price

 

 

2022

 

 

Price

 

 

Life

 

$27.00

 

 

 

2,222

 

 

 

3.08

 

 

$27.00

 

 

 

2,222

 

 

$27.00

 

 

 

3.08

 

Outstanding options

 

 

 

2,222

 

 

 

3.08

 

 

$27.00

 

 

 

2,222

 

 

$27.00

 

 

 

3.08

 

 

As of March 31, 2023, the Company had approximately $0 of unrecognized pre-tax non-cash compensation expense.

 

Restricted Stock Awards

 

Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holder of a restricted stock award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a shareholder of the Company, including the right to vote the shares. The value of stock awards that vest over time was established by the market price on the date of its grant. A summary of the Company’s restricted stock activity for the nine months ended  March 31, 2023 is presented in the following table:

 

 

 

For the nine months ended

 

 

 

March 31, 2023

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at June 30, 2022

 

 

7,407

 

 

$2.13

 

Granted

 

 

3,405,000

 

 

$0.31

 

Forfeited

 

 

(40,000 )

 

$0.31

 

Vested

 

 

(1,580,741 )

 

$0.34

 

Unvested at March 31, 2023

 

 

1,791,666

 

 

$0.31

 

 

Unrecognized compensation expense related to outstanding restricted stock awards to employees and directors as of March 31, 2023 was $555,417 and is expected to be recognized over a weighted average period of 0.75 years.  The recognition of expense related to vested shares is accounted for as stock-based consulting expense and stock-based compensation expense for a total of $542,149 for the nine months ended  March 31, 2023.

 

 
20

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

 

NOTE 9: RELATED PARTY TRANSACTIONS

 

Equity transactions with related parties are described in Note 7.

 

From time to time we have borrowed funds from Mr. Mark Lucky, our Chief Executive Officer and from certain of our directors, for working capital. The advances were payable upon demand and were interest free. At March 31, 2023 there was $72,500 outstanding of such advances made to the Company.

 

NOTE 10: COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

The Company operates virtually, with no office space rented. The Company has no future minimum annual payments under non-cancelable operating leases at March 31, 2023.

 

Contingencies

 

The Company accounts for contingent liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of March 31, 2023, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.

 

License Contingent Consideration

 

Our license agreement with The MITRE Corporation includes provisions for a royalty payment on revenues collected of 6%. As of March 31, 2023, we have not generated any revenue related to these license agreements.

 

Legal Claims

 

The Company is subject to litigation, claims, investigations, and audits arising from time to time in the ordinary course of business. Although legal proceedings are inherently unpredictable, the Company believes that it has valid defenses with respect to any matters currently pending against the Company and intends to defend itself vigorously. The outcome of these matters, individually and in the aggregate, is not expected to have a material impact on the Company’s cash flows, results of operations, or financial position.

 

NOTE 11: SUBSEQUENT EVENTS

 

In April 2023 our directors and officers restricted stock vested 173,334 shares of our $0.0001 par value common stock, valued at $53,734, or an average price per share of $0.31.

 

In April 2023 our employees restricted stock vested 76,667 shares of our $0.0001 par value common stock to three employees as compensation, valued at $27,167, or an average price per share of $0.35. 

 

In April 2023 the Company raised $40,250 through the sale of 2,012,500 shares of its $0.0001 par value common stock at a price of $0.02 per share.

 

In April 2023 our consultants restricted stock vested 29,167 shares of our $0.0001 par value common stock as compensation, valued at $9,042, or an average price per share of $0.31.

 

In April 2023 the Company issued 2,722,941 shares of its $0.0001 par value common stock upon the conversion of principal and interest of $219,058 of its outstanding convertible notes, valued at $0.084 per share.

 

In May 2023 the Company announced that it repaid and satisfied approximately $93,000 of principal and accrued interest related to its toxic convertible note. The note was initially issued in October, 2022 and was paid off with cash advances from the Company’s officer and directors.

 

 

 
21

Table of Contents

 

ITEM 2. Management’s Discussion and Analysis and Results of Operations

 

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See ‘‘Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements.

 

Overview

 

Visium Technologies, Inc. was incorporated in Nevada as Jaguar Investments, Inc. during October 1987. During March 2003, a wholly owned subsidiary of the Company merged with Freight Rate, Inc., a development stage company in the logistics software business. During May 2003, the Company changed its name to Power2Ship, Inc. During October 2006, the Company merged with a newly formed, wholly owned subsidiary, Fittipaldi Logistics, Inc., a Nevada corporation, with the Company surviving but its name changed to Fittipaldi Logistics, Inc. effective November 2006. During December 2007, the Company merged with a newly formed, wholly owned subsidiary, NuState Energy Holdings, Inc., a Nevada corporation, with the Company surviving but renamed NuState Energy Holdings, Inc. effective December 2007. In March 2018, the Company brought in a new management team and changed its name to Visium Technologies, Inc.

 

Visium is a provider of cyber security visualization, big data analytics, and automation that operates in the traditional cyber security space, as well as in the cloud-based technology and Internet of Things spaces. Visium provides cybersecurity technology solutions, tools, and services to support commercial enterprises and government’s ability to protect their data. Visium’s CyGraph technology provides visualization, advanced cyber monitoring intelligence, data modeling, analytics, and automation to help reduce risk, simplify cyber security, and deliver better security outcomes.

 

In March 2019, Visium entered into a software license agreement with MITRE Corporation to license a patented technology, known as CyGraph, a tool for cyber warfare analytics, visualization, and knowledge management. CyGraph is a military-grade highly scalable big data analytics tool for Cybersecurity, based on graph database technology. The development of the technology was sponsored by, and is currently in use by US Army Cyber Command. CyGraph provides advanced analytics for cybersecurity situational awareness that is scalable, flexible, and comprehensive. Visium has completed significant proprietary product development efforts to commercialize CyGraph which the Company has rebranded as TruContextTM.

 

Plan of Operation

Visium operates in the traditional cyber security and data analytics space, and provides solutions, tools and services related to Security information and event management (SIEM).  Our TruContext technology provides visualization, advanced cyber monitoring intelligence, data modeling, analytics and automation to help reduce risk, simplify cyber security and deliver better security outcomes. Visium currently plans to generate revenue in three primary ways –

 

·

through a virtual appliance model, primarily targeted to the Federal government, charging a seat license

·

through a SaaS model, charging a recurring monthly license fee for TruContext; and

·

through professional services to support and deliver cybersecurity solutions and services to its customers

 

The Company has developed integration partnerships with larger established technology companies and is using these partnerships as part of its go-to-market strategy.  In addition, the Company has partnered with value-added resellers that sell to the federal government and commercial markets.  The Company is focused on digital risk management, cybersecurity solutions, and technology services for network physical security, the Cloud, and mobility solutions. We solve mission-critical problems.

 

COVID-19 Update

 

The COVID-19 pandemic and related developments have caused and may continue to cause new and potential customers to experience rapidly changing conditions and disruptions to their businesses. It can be difficult to predict customer demand, especially as our customers’ priorities, resources and economic outlook change, along with other shifting market conditions. These shifts have occurred and may in the future occur more quickly than we anticipate.

 

 Employees

 

As of March 31, 2023, we had six (6) full time employees.

 

 
22

Table of Contents

 

Third-Party Service Providers

 

We are heavily reliant on our technology and infrastructure to provide our products and services to our customers. For example, we host many of our products using third-party data center facilities, and we do not control the operation of these facilities. In addition, we rely on certain technology that we license from third parties, including third-party commercial software and open source software, which is used with certain of our solutions.

 

Governmental Regulation

 

We use, store or disclose an increasingly high volume, variety, and velocity of personal information, including from employees and customers, in connection with the operation of our business. The personal information we process is subject to an increasing number of federal, state, local, and foreign laws regarding privacy and data security.

 

Competition

 

The markets for our solutions are highly competitive, and we expect both the requirements and pricing competition to increase, particularly given the increasingly sophisticated attacks, changing customer preferences and requirements, current economic pressures, and market consolidation. Competitive pressures in these markets may result in price reductions, reduced margins, loss of market share and inability to gain market share, and a decline in sales, any one of which could seriously impact our business, financial condition, results of operations, and cash flows. We may face competition due to changes in the manner that organizations utilize IT assets and the security solutions applied to them, such as the provision of privileged account security functionalities as part of public cloud providers’ infrastructure offerings, or cloud-based identity management solutions. Limited IT budgets may also result in competition with providers of other advanced threat protection solutions such as McAfee, LLC, Palo Alto Networks, Splunk Inc., and NortonLifeLock, Inc. (formerly known as Symantec Corporation acquired by Broadcom Inc.). We also may compete, to a certain extent, with vendors that offer products or services in adjacent or complementary markets to privileged access management, including identity management vendors and cloud platform providers such as Amazon Web Services, Google Cloud Platform, and Microsoft Azure.

 

Available Information

 

All reports of the Company filed with the SEC are available free of charge through the SEC’s website at www.sec.gov. In addition, the public may read and copy materials filed by the Company at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. The public may also obtain additional information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330.

 

Our principal offices are located at 4094 Majestic Lane, Suite 360, Fairfax, Virginia 22033. Our telephone number is (703) 273-0383.

 

Our common stock is quoted on the OTC Pink under the symbol “VISM”.

 

 
23

Table of Contents

  

VISIUM TECHNOLOGIES, INC.

RESULTS OF OPERATIONS

 

Three and Nine Month Periods Ended March 31, 2023 and 2022

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net revenues

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

567,979

 

 

 

1,296,611

 

 

 

1,461,560

 

 

 

3,761,236

 

Development expense

 

 

73,755

 

 

 

78,289

 

 

 

175,707

 

 

 

274,614

 

Total Operating Expenses

 

 

641,734

 

 

 

1,374,900

 

 

 

1,637,267

 

 

 

4,035,850

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from Operations

 

 

(641,734 )

 

 

(1,374,900 )

 

 

(1,637,267 )

 

 

(4,035,850 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expenses):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on change in fair value of derivative liabilities

 

 

(50,384 )

 

 

(76,707 )

 

 

(84,246 )

 

 

(20,632 )

Derivative liability expense

 

 

(4,634 )

 

 

-

 

 

 

(62,773 )

 

 

-

 

Gain (loss) on extinguishment of debt

 

 

(15,068 )

 

 

-

 

 

 

(519,993 )

 

 

-

 

Interest expense

 

 

(20,265 )

 

 

(52,587 )

 

 

(187,205 )

 

 

(554,262 )

Total other income (expenses)

 

 

(90,354 )

 

 

(129,294 )

 

 

(854,217 )

 

 

(574,624 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(732,085 )

 

$(1,504,194 )

 

$(2,491,484 )

 

$(4,610,474 )

 

Selling, General, and Administrative Expenses

 

Nine Month Period Ended March 31, 2023

 

For the nine months ended March 31, 2023, selling, general and administrative expenses were $1,461,560 as compared to $3,761,236 for the nine months ended March 31, 2022. For the nine month periods ended March 31, 2023 and 2022 selling, general and administrative expenses consisted of the following:

 

 

 

Nine Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Accounting expense

 

$45,450

 

 

$50,866

 

Consulting fees

 

 

35,020

 

 

 

24,575

 

Salaries

 

 

772,858

 

 

 

722,283

 

Legal and professional fees

 

 

30,652

 

 

 

381,333

 

Travel expense

 

 

249

 

 

 

34

 

Occupancy expense

 

 

1,498

 

 

 

582

 

Telephone expense

 

 

3,395

 

 

 

3,070

 

Marketing expense

 

 

1,066

 

 

 

203,527

 

Website expense

 

 

61

 

 

 

23,425

 

Investor relations expense

 

 

13,688

 

 

 

0

 

Stock based consulting expense

 

 

36,989

 

 

 

1,075,132

 

Stock based compensation expense

 

 

505,159

 

 

 

1,216,472

 

Other

 

 

15,475

 

 

 

59,937

 

 

 

$1,461,560

 

 

$3,761,236

 

 

The decrease in selling, general and administrative expenses of $2,299,676 during fiscal 2023, when compared with the prior year, is primarily due to a decrease in stock-based consulting expense of $711,313, a decrease in stock-based compensation expense of $1,038,143, lower legal and professional fees expense of $350,681, and lower marketing expense of $202,461, offset by higher salaries expense of $50,575 and higher investor relations expense of $13,688.

 

We believe that our selling, general, and administrative expenses will be flat to slightly higher over the rest of the current fiscal year, driven by increased expenses related to an increase in our business activity over the remainder of fiscal 2023.

 

 
24

Table of Contents

  

Development Expense

 

 

 

Nine Months Ended

 

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Development expense

 

$175,707

 

 

$274,614

 

 

(36

%) 

 

Development expense represents the expense to further enhance and commercialize CyGraph. We believe that we will incur an additional $50,000 in development expense during the remainder of fiscal 2023.

 

Change in Fair Value of Derivative Liabilities

 

 

 

Nine Months Ended

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Gain (loss) on change in fair value of derivative liabilities

 

$(84,246 )

 

$(20,362 )

 

(314

%)

 

The change in fair value of derivative liabilities results from the changes in the fair value of the derivative liability due to the application of ASC 815, resulting in either income or expense, depending on the difference in fair value of the derivative liabilities between their measurement dates driven by the change in the per share price of the Company’s common stock.

 

Derivative Liability Expense

 

 

 

Nine Months Ended

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Derivative liability expense

 

$(62,773 )

 

$-

 

 

 

N/A

 

 

The Company issued convertible notes in October 2022 and March 2023which provisions contained variable price conversion terms, resulting in a derivative liability expense, measured as of the issuance date of the notes.

 

 
25

Table of Contents

  

Interest Expense

 

 

 

Nine Months Ended

 

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Interest expense

 

$187,205

 

 

$554,262

 

 

(66

%) 

 

Interest expense represents stated interest of notes and convertible notes payable as well as amortization of debt discount. Interest expense is lower for the Nine Months Ended March 31, 2023 due to lower debt discount amortization of $319,329 as compared to the prior year period.

 

Loss on extinguishment of debt 

 

 

 

Nine Months Ended

 

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Loss on extinguishment of debt

 

$519,993

 

 

$-

 

 

 

N/A

 

 

In September 2022 we issued 138,667 warrants with a five year life, and a fixed exercise price of $1.35 per share, as part of a modification to three outstanding convertible notes payable. The Company evaluated these amendments under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the issuance of these warrants in exchange for deferring the interim interest payments that were due resulted in significant and consequential changes to the economic substance of the debt and thus resulted in accounting for these modifications as an extinguishment of the debt.  Under ASC 470-50, the issuance of these warrants resulted in a loss on the extinguishment of debt, as follows:

 

Value of warrants issued

 

$186,972

 

Write-off of unamortized debt discount

 

 

317,953

 

Loss on extinguishment of debt

 

$504,925

 

 

During the nine months ended March 31, 2023 we recorded a loss on the conversion of convertible note totaling $15,068, which is recorded in the Consolidated Statement of Operations as loss on extinguishment of debt.

 

A recap of the Loss on extinguishment of debt follows:

 

Loss on extinguishment of debt related to warrants

 

$504,925

 

Loss on extinguishment of debt related to note conversions

 

 

15,068

 

 

 

$519,993

 

 

Three Month Period Ended March 31, 2023

 

For the three months ended March 31, 2023, selling, general and administrative expenses were $567,979 as compared to $1,296,611 for the three months ended March 31, 2022. For the three months ended March 31, 2023 and 2022 selling, general and administrative expenses consisted of the following:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

Accounting expense

 

$20,093

 

 

$14,821

 

Consulting fees

 

 

25,020

 

 

 

15,725

 

Salaries

 

 

237,578

 

 

 

285,138

 

Legal and professional fees

 

 

14,752

 

 

 

103,303

 

Travel expense

 

 

0

 

 

 

0

 

Occupancy expense

 

 

442

 

 

 

204 )

Telephone expense

 

 

1,245

 

 

 

968

 

Marketing expense

 

 

774

 

 

 

200,148

 

Website expense

 

 

21

 

 

 

3,929

 

Stock based consulting expense

 

 

13,400

 

 

 

0

 

Stock based compensation expense

 

 

18,083

 

 

 

369,800

 

Other

 

 

232,500

 

 

 

293,424

 

 

 

$567,979

 

 

$1,296,611

 

 

The decrease in selling, general and administrative expenses of $728,632 for the three months ended March 31, 2023, when compared with the prior year period, is primarily due to a decrease in stock-based consulting expense of $351,717, a decrease in stock-based compensation expense of $60,924, lower salaries expense of $47,560, lower website expense of $3,908, and lower legal and professional fees expense of $88,551, offset by higher investor relations expense of $13,400.

 

Development Expense

 

 

 

Three-Months Ended

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Development expense

 

$73,755

 

 

$78,289

 

 

(6

%)

 

Change in Fair Value of Derivative Liabilities

 

 

 

Three-Months Ended

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Gain (loss) on change in fair value of derivative liabilities

 

$(50,384 )

 

$(76,707 )

 

 

(34 )%

 

The change in fair value of derivative liabilities results from the changes in the fair value of the derivative liability due to the application of ASC 815, resulting in either income or expense, depending on the difference in fair value of the derivative liabilities between their measurement dates driven by the change in the per share price of the Company’s common stock.

 

 
26

Table of Contents

  

Interest Expense

 

 

 

Three-Months Ended

 

 

 

 

 

 

March 31,

 

 

%

 

 

 

2023

 

 

2022

 

 

Change

 

Interest expense

 

$20,265

 

 

$52,587

 

 

(62

%)

 

Interest expense represents stated interest of notes and convertible notes payable as well as amortization of debt discount. Interest expense is lower for the three months ended March 31, 2023 due to higher principal balances and higher debt discount amortization as compared to the prior year period.

 

Liquidity and Capital Resources

 

 

 

Balance at

 

 

 

March 31,

2023

 

 

June 30,

2022

 

Cash

 

$46,750

 

 

 

136,990

 

Accounts payable and accrued expenses

 

 

(661,164 )

 

 

(596,464 )

Accrued compensation

 

 

(1,190,629 )

 

 

(614,589 )

Notes, convertible notes, and accrued interest payable

 

$(2,209,128 )

 

 

(1,684,199 )

 

We do not have any material commitments for capital expenditures.

 

The objective of liquidity management is to ensure that we have ready access to sufficient funds to meet commitments and effectively implement our growth strategy. Our primary sources are financing activities such as the issuance of notes payable and convertible notes payable. In the past, we have mostly relied on debt and equity financing to provide for our operating needs.

 

We cannot ascertain that we have sufficient funds from operations to fund our ongoing operating requirements through June 30, 2023. We may need to raise funds to enhance our working capital and use them for strategic purposes. If such need arises, we intend to generate proceeds from either debt or equity financing.

 

We intend to finance our operations using a mix of equity and debt financing. We do not anticipate incurring capital expenditures for the foreseeable future. We anticipate that we will need to raise approximately $180,000 per year in the near term to finance the recurring costs of being a publicly-traded company.

 

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis. The Company has used net cash in its operating activities of $452,740 and $1,742,572 during the nine month periods ended March 31, 2023 and 2022, respectively, and has a working capital deficit of approximately $4.25 million and $2.8 million at March 31, 2023 and June 30, 2022, respectively. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due and to generate profitable operations in the future. Management plans may continue to provide for its capital requirements by issuing additional equity securities and debt. The outcome of these matters cannot be predicted at this time and there are no assurances that if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results.

 

 
27

Table of Contents

  

Nine Months Ended March 31, 2023

 

Net cash used in operations during the nine months ended March 31, 2023 decreased by approximately $1,289,831 or 74% from the same period during fiscal year 2022. The decrease in cash used in operations is primarily due to the decrease in marketing and product development expenses, cash paid for legal and professional fees, and consulting and business development expense. This cash was obtained through the issuance of two convertible notes that netted the Company $140,000, the issuance of two promissory notes that netted the Company $150,000, and advances from Directors of the Company of $72,500 during the nine months ended March 31, 2023.

 

Nine Months Ended March 31, 2022

 

Net cash used in operations during the nine months ended March 31, 2022 increased by approximately $744,688 or 416% from the same period during fiscal year 2020. The increase in cash used in operations is primarily due to the increase in product development expenses, cash paid for legal and professional fees, and consulting and business development expense. This cash was obtained through the sale of common stock that netted the Company $1,500,000.

 

Capital Raising Transactions

 

Sale of Common Stock

 

We generated net proceeds of $140,000 from the issuance of two convertible notes during the nine month period ended March 31, 2023.

 

We generated net proceeds of $150,000 from the issuance of two one-year promissory notes during the nine month period ended March 31, 2023.

 

Other outstanding obligations at March 31, 2023

 

Convertible Notes Payable

 

The Company had convertible promissory notes aggregating $1,431,790 outstanding at March 31, 2023. The accrued interest amounted to approximately $229,624 as of March 31, 2023. The convertible notes payable bear interest at rates ranging between 0% and 18% per annum. Interest is generally payable monthly. The convertible notes payable are generally convertible at rates ranging between $0.21 and $22,500 per share, at the holders’ option. At March 31, 2023, $324,009 of the convertible promissory notes have matured and are in default.

 

Notes Payable

 

The Company had promissory notes aggregating $355,000 at March 31, 2023. The related accrued interest amounted to approximately $204,452 at March 31, 2023. The Notes Payable bear interest at rates ranging between 8% and 16% per annum. Interest is generally payable monthly.

 

 
28

Table of Contents

  

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable to a smaller reporting company.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our management assessed the effectiveness of our internal control over financial reporting as of March 31, 2023. In making this assessment, our management used criteria issued by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control Over Financial Reporting – Guidance for Smaller Public Companies.

 

During our assessment of the design and the effectiveness of internal control over financial reporting as of March 31, 2023, management identified the following material weaknesses:

 

 

While we have processes in place, there are no formal written policies and procedures related to certain financial reporting processes;

 

 

 

 

There is no formal documentation in which management specified financial reporting objectives to enable the identification of risks, including fraud risks;

 

 

 

 

Our Board of Directors consisted of six members, however we lack the resources and personnel to implement proper segregation of duties or other risk mitigation systems.

 

A material weakness is “a significant deficiency, or a combination of significant deficiencies, that result in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected by us in a timely manner.” A significant deficiency is a deficiency or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the registrant’s financial reporting.

 

We intend to gradually improve our internal control over financial reporting to the extent that we can allocate resources to such improvements. We intend to prioritize the design of our internal control over financial reporting starting with our control environment and risk assessments and ending with control activities, information and communication activities, and monitoring activities. Although we believe the time to adapt in the next year will help position us to provide improved internal control functions into the future, in the interim, these changes caused control deficiencies, which in the aggregate resulted in a material weakness. Due to the existence of these material weaknesses, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our internal control over financial reporting was not effective as of March 31, 2023.

 

This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to the rules of the SEC that permit smaller reporting companies to provide only the management’s report in this annual report.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended March 31, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
29

Table of Contents

  

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

At March 31, 2023 the Company is not the subject of, or party to, any pending or threatened, material legal actions.

 

However, from time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

Item 1A. Risk Factors.

 

In addition to the other information set forth in this report, you should carefully consider the factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K filed on October 4, 2022, which could materially affect our business operations, financial condition or future results. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business operations and/or financial condition. There have been no material changes to our risk factors since the filing of our Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Convertible Notes Payable

During the nine months ended March 31, 2023 the Company issued 976,100 shares of its common stock related to the conversion of $290,464 of principal and accrued interest for three of its convertible notes payable, at an average contract conversion price of $0.30 per share.  These convertible notes have terms that include fixed conversion prices, and therefore the notes were converted consistent with the contractual conversion prices of each note.

 

Stock Based Compensation

During the nine months ended March 31, 2023 the Company issued 1,045,932 shares of its $0.0001 par value common stock as compensation to its directors and officers. The shares were valued at $361,013, or $0.35 per share, based on the share price at the time of the transactions.

 

During the nine months ended March 31, 2023 69,815 shares of its $0.0001 par value common stock vested to two consultants, as compensation under two separate consulting agreements. The shares were valued at $36,956, or $0.53 per share.

 

During the nine months ended March 31, 2023 the Company issued 465,001 shares of its $0.0001 par value common stock as compensation to its employees. The shares were valued at $144,150, or $0.31 per share, based on the share price at the time of the transaction.

 

Warrant Exercises

During the nine months ended March 31, 2023 the Company issued 68,755 shares of its $0.0001 par value common stock pursuant to two cashless exercises.

 

Commitment Shares

During the nine months ended March 31, 2023 the Company issued 66,668 shares of its $0.0001 par value common stock to two investors as commitment shares pursuant to the issuance of promissory notes.  The shares were valued at $14,000, or $0.21 per share, the market price on the date of the issuance.

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not applicable to our operations.

 

Item 5. Other Information.

 

None

 

Item 6. Exhibits

 

31.1

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *

 

 

31.2

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *

 

 

32.1

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *

 

 

32.2

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *

 

*

Filed herewith.

 

 
30

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

VISIUM TECHNOLOGIES, INC.

 

 

 

 

 

 

By:

/S/ Mark B. Lucky

 

May 15, 2023

 

Mark B. Lucky

 

 

 

CEO, principal executive officer

 

 

 

 

 

 

By:

/S/ Mark Lucky

 

May 15, 2023

 

Mark Lucky

 

 

 

CFO, principal accounting officer

 

 

 
31

 

Visium Technologies (PK) (USOTC:VISM)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more Visium Technologies (PK) Charts.
Visium Technologies (PK) (USOTC:VISM)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more Visium Technologies (PK) Charts.